BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puijk RS, Ziedses des Plantes V, Nieuwenhuizen S, Ruarus AH, Vroomen LGPH, de Jong MC, Geboers B, Hoedemaker-Boon CJ, Thöne-Passchier DH, Gerçek CC, de Vries JJJ, van den Tol PMP, Scheffer HJ, Meijerink MR. Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts. Cardiovasc Intervent Radiol 2019;42:1597-608. [PMID: 31243542 DOI: 10.1007/s00270-019-02273-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Lin Y, Bale R, Brock KK, Odisio BC. Contemporary evidence on colorectal liver metastases ablation: toward a paradigm shift in locoregional treatment. International Journal of Hyperthermia 2022;39:649-63. [DOI: 10.1080/02656736.2021.1970245] [Reference Citation Analysis]
2 Wang Y, Xu B, Zhou J, Wu X. Propofol activates AMPK to inhibit the growth of HepG2 cells in vitro and hepatocarcinogenesis in xenograft mouse tumor models by inducing autophagy. J Gastrointest Oncol 2020;11:1322-32. [PMID: 33457004 DOI: 10.21037/jgo-20-472] [Reference Citation Analysis]
3 Qi Y, Yao X, Du X. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1. IUBMB Life 2020;72:452-64. [PMID: 31651086 DOI: 10.1002/iub.2171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Lin YM, Paolucci I, Brock KK, Odisio BC. Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward. Cancers (Basel) 2021;13:3926. [PMID: 34439081 DOI: 10.3390/cancers13163926] [Reference Citation Analysis]
5 Koo BW, Lim DJ, Oh AY, Na HS. Retrospective Comparison between the Effects of Propofol and Inhalation Anesthetics on Postoperative Recurrence of Early- and Intermediate-Stage Hepatocellular Carcinoma. Med Princ Pract 2020;29:422-8. [PMID: 32074612 DOI: 10.1159/000506637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Wu WT, Zhou WZ, Zu QQ, Jia ZY, Leng B, Liu S, Shi HB, Chen Y. Risk factor for vital signs elevation during percutaneous microwave ablation of liver tumor under deep sedation. Jpn J Radiol 2021. [PMID: 34173972 DOI: 10.1007/s11604-021-01158-w] [Reference Citation Analysis]
7 Puijk RS, Dijkstra M, van den Bemd BAT, Ruarus AH, Nieuwenhuizen S, Geboers B, Timmer FEF, Schouten EAC, de Vries JJJ, van der Meijs BB, Nielsen K, Swijnenburg RJ, van den Tol MP, Versteeg KS, Lissenberg-Witte BI, Scheffer HJ, Meijerink MR. Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE). Cardiovasc Intervent Radiol 2022. [PMID: 35585138 DOI: 10.1007/s00270-022-03152-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Calandri M, Gazzera C, Giurazza F, Yevich S, Strazzarino GA, Brino J, Marra P, Contegiacomo A, Bargellini I, Cariati M, Fonio P, Veltri A. Oligometastatic Colorectal Cancer Management: A Survey of the Italian College of Interventional Radiology. Cardiovasc Intervent Radiol 2020;43:1474-83. [PMID: 32449016 DOI: 10.1007/s00270-020-02516-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Mauri G, Monfardini L, Garnero A, Zampino MG, Orsi F, Della Vigna P, Bonomo G, Varano GM, Busso M, Gazzera C, Fonio P, Veltri A, Calandri M. Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin. Cancers (Basel) 2021;13:2617. [PMID: 34073585 DOI: 10.3390/cancers13112617] [Reference Citation Analysis]